BSX Boston Scientific Corp
Company Analysis
Latest News
Boston Scientific shares tumble, hit by global cyberattack and FDA recall
Boston Scientific shares fell following disclosures of a global cyberattack and a high-risk product recall. The company identified a cyberattack on August 25...
🔴 Boston Scientific is trading 4.3% down today after a cybersecurity incident disrupted customer-order processing
Boston Scientific is trading at $47.72, down -4.30%, after disclosing a cybersecurity incident identified on August 25, 2026. • The disruption affects...
Boston Scientific Discloses Cybersecurity Incident Disrupting Global Operations and Shipments
Boston Scientific Corporation has disclosed a cybersecurity incident, identified on August 25, 2026, that is causing a global disruption to its operations. The...
🔴 Boston Scientific is trading 5% down in pre-market after cyberattack disrupted global operations
Boston Scientific is trading at $47.33 (-5.07%) after disclosing a cybersecurity incident detected on August 25, 2026, that disrupted global operations. •...
Steve Cohen's Point72 slashes Boston Scientific (BSX) stake by 90%
In a significant reversal from the prior quarter, Steve Cohen's Point72 Asset Management reduced its stake in medical device maker Boston Scientific (BSX) by...
🔴 Boston Scientific is trading 4.06% down today
Boston Scientific is trading 4.06% down at $49.90, reversing part of its 3.05% gain on August 19, with no clear immediate catalyst identified. - No new...
🟢 Boston Scientific rises 4.0% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation
With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...
BlackRock Becomes Largest Boston Scientific Shareholder, Following $5B Buyback Plan
BlackRock Inc. acquired 129.7 million shares of Boston Scientific Corporation, according to a recent Form 13F filing. The investment is valued at approximately...
🟢 Boston Scientific is trading 4.03% up today as healthcare gains 1.31% during session
Boston Scientific is trading 4.03% up now at $49.66, as healthcare gains 1.31% during the session—the clearest explanation for today’s move. - Rebounding...
🔴 Boston Scientific is trading 4% down today on lowered guidance and analyst estimate cuts
Boston Scientific is trading 4% down at $47.11 as investors react to recently lowered guidance and subsequent analyst estimate cuts. • A fresh Zacks Bear of...
🟢 Boston Scientific is trading 4.2% up today amid a broader risk-on market move
Boston Scientific is trading at $48.71 (+4.24%) as broader U.S. equities rally in a risk-on session. • The advance appears driven by market-wide strength...
🔴 Boston Scientific is trading 5.7% down today as cautious guidance offsets Q2 earnings beat
Boston Scientific is trading 5.7% down at $43.45 after reporting a Q2 2026 earnings beat but issuing more cautious forward guidance. • Management guided to...
🔴 Boston Scientific is trading 7.2% down today on cautious Q3 guidance and restructuring plan
Boston Scientific is trading 7.2% down at $42.75 as cautious Q3 guidance and a major restructuring plan overshadow a Q2 earnings beat. • While revenue and EPS...
Boston Scientific Beats on Q2 Earnings and Unveils a $500 Million Cost-Cutting Plan — But Can It Outrun the Watchman Problem?
Shares of Boston Scientific surged 8.3% to $49.90 Wednesday morning after the medical-device maker delivered a Q2 earnings surprise and paired it with an...
🟢 Boston Scientific is trading 8.3% up today after Q2 earnings beat and restructuring update
Boston Scientific is trading 8.3% up at $49.90 after reporting stronger-than-expected Q2 2026 results and updating investors on a major restructuring plan. •...
Boston Scientific's second quarter revenue grew 7.5% to beat estimates, driven by strong Cardiovascular performance.
Boston Scientific reported second quarter 2026 net sales of $5.442 billion, a 7.5% year-over-year increase, and adjusted EPS of $0.86, up from $0.75 in the...
Boston Scientific Corp Q2 2026 Earnings Preview: What Analysts Expect on July 29, 2026
Analysts expect Boston Scientific to report consensus revenue of $5.38 billion (+6.5% YoY) and adjusted EPS of $0.83 (+10.7% YoY), while the stock trades near...
BSX Announces $700-800M Global Restructuring Plan Targeting ~$500M Annual Savings
Boston Scientific announced its Board of Directors has approved a new global restructuring program, the "2026 Restructuring Plan," designed to drive sustained...
🟢 Boston Scientific is trading 4.4% up today as shares rebound from FDA-related recall concerns
Boston Scientific is trading 4.4% up at $46.19 as shares rebound following last week’s FDA alert on ENROUTE neuroprotection systems and associated recall...
Boston Scientific Recalls ENROUTE Systems, Citing Potential Stroke Risk
The FDA issued an alert on July 24, 2026, regarding specific lots of Boston Scientific’s ENROUTE Transcarotid Neuroprotection and Neuroprotection Plus Systems....